| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 9.595 | 8.206 | 3.194 | 775 | 7.273 | 20.596 | 57.671 |
| Total Income - EUR | - | - | - | 9.595 | 8.206 | 3.194 | 775 | 7.273 | 20.596 | 57.671 |
| Total Expenses - EUR | - | - | - | 295 | 3.348 | 65 | 61 | 65 | 199 | 5.866 |
| Gross Profit/Loss - EUR | - | - | - | 9.300 | 4.858 | 3.129 | 714 | 7.208 | 20.397 | 51.805 |
| Net Profit/Loss - EUR | - | - | - | 9.012 | 4.612 | 3.037 | 691 | 6.990 | 17.131 | 43.515 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bogdalin Surgery S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 13.843 |
| Current Assets | - | - | - | 9.201 | 13.541 | 16.281 | 16.612 | 14.200 | 18.735 | 49.516 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 885 | 868 | 886 | 10.420 | 11.246 | 38.946 |
| Cash | - | - | - | 9.201 | 12.656 | 15.413 | 15.726 | 3.780 | 7.489 | 10.570 |
| Shareholders Funds | - | - | - | 9.055 | 13.491 | 16.273 | 16.603 | 13.505 | 17.252 | 60.670 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 146 | 50 | 8 | 10 | 695 | 1.483 | 2.689 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bogdalin Surgery S.r.l.